Exane Derivatives Bridge Bio Pharma, Inc. Transaction History

Exane Derivatives

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$7.34 - $17.16 $23,825 - $55,701	-3,246 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$11.38 - $53.41 $11,368 - $53,356	999 Added 44.46%	3,246 $54,000
Q3 2021 Oct 26, 2021	SELL	$46.87 - $64.24 $15,045 - $20,621	-321 Reduced 12.5%	2,247 $105,000
Q2 2021 Jul 28, 2021	BUY	$46.47 - $63.93 $43,217 - $59,454	930 Added 56.78%	2,568 $156,000
Q1 2021 Apr 30, 2021	BUY	$55.47 - $72.35 $63,402 - $82,696	1,143 Added 230.91%	1,638 $100,000
Q4 2020 Jan 27, 2021	BUY	$38.38 - $71.11 $18,998 - $35,199	495 New	495 $35,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.